4//SEC Filing
Chapman Marcus 4
Accession 0000899243-20-002422
CIK 0001609809other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:07 PM ET
Size
5.5 KB
Accession
0000899243-20-002422
Insider Transaction Report
Form 4
Chapman Marcus
See Remarks
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2020-01-29+125,000→ 125,000 totalExercise: $3.30Exp: 2030-01-28→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on January 29, 2021. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001770404
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:07 PM ET
- Size
- 5.5 KB